Categorizing a prognostic variable: review of methods, code for easy implementation and applications to decision-making about cancer treatments
Madhu Mazumdar, Jill R. Glassman · Statistics in Medicine · 2000
Categorizing prognostic variables is essential for their use in clinical decision-making. Often a single cutpoint that stratifies patients into high-risk and low-risk categories is sought. These categories may be used for making treatment recommendations, determining study eligibility, or to control for varying patient prognoses in the design of a clinical trial. Methods used to categorize variables include: biological determination (most desirable but often unavailable); arbitrary selection of a cutpoint at the median value; graphical examination of the data for a threshold effect; and exploration of all observed values for the one which best separates the risk groups according to a chi-squared test. The last method, called the minimum p-value approach, involves multiple testing which inflates the type I error rates. Several methods for adjusting the inflated p-values have been proposed but remain infrequently used. Exploratory methods for categorization and the minimum p-value approach with its various p-value corrections are reviewed, and code for their easy implementation is provided. The combined use of these methods is recommended, and demonstrated in the context of two cancer-related examples which highlight a variety of the issues involved in the categorization of prognostic variables.
Cited by 367 works. doi:10.1002/(sici)1097-0258(20000115)19:1<113::aid-sim245>3.0.co;2-o
Authors
References
- Nonparametric Estimation from Incomplete Observations
- Nonparametric Estimation from Incomplete Observations
- Evaluation of survival data and two new rank order statistics arising in its consideration.
- Categorical Data Analysis
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
- Cancer Chemotherapy Reports
- Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors
- Maximally Selected Chi Square Statistics
- Clinical Cancer Research
- Maximally Selected Rank Statistics